New Zealand markets open in 2 hours 5 minutes

Lixte Biotechnology Holdings, Inc. (8640.F)

Frankfurt - Frankfurt Delayed price. Currency in USD
Add to watchlist
0.0000-6.1000 (-100.00%)
As of 08:57AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
828.079
898.1
1,349
1,737
1,224
Selling general and administrative
3,859
4,192
4,962
4,984
2,043
Total operating expenses
4,687
5,090
6,311
6,720
3,266
Operating income or loss
-4,687
-5,090
-6,311
-6,720
-3,266
Interest expense
19.558
16.233
8.875
7.414
3.674
Total other income/expenses net
0.504
1.954
-3.374
-1.163
0.89
Income before tax
-4,691
-5,087
-6,313
-6,728
-3,265
Income from continuing operations
-4,691
-5,087
-6,313
-6,728
-3,265
Net income
-4,691
-5,087
-6,313
-6,728
-3,265
Net income available to common shareholders
-4,691
-5,087
-6,313
-6,728
-3,265
Basic EPS
-3.24
-
-4.00
-5.00
-2.90
Diluted EPS
-3.24
-
-4.00
-5.00
-2.90
Basic average shares
1,769
-
1,582
1,347
1,128
Diluted average shares
1,769
-
1,582
1,347
1,128